4.2 Article

Spinal solitary fibrous tumor of the neck: Next-generation sequencing-based analysis of genomic aberrations

Journal

AURIS NASUS LARYNX
Volume 47, Issue 6, Pages 1058-1063

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.anl.2019.12.001

Keywords

Solitary fibrous tumor; Whole-exome sequencing; RNA sequencing; Todai OncoPanel; TERT

Funding

  1. Program for Integrated Database of Clinical and Genomic Information from the Japan Agency for Medical Research and Development, AMED [JP18kk0205003]
  2. Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development, AMED [JP17am0001001]
  3. Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, AMED [JP17ck0106252]
  4. Project for Cancer Research And Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development, AMED [JP17cm0106502]
  5. Sysmex

Ask authors/readers for more resources

A solitary fibrous tumor (SFT) is a rare neoplasm with recurrent NAB2-STAT6 gene fusion. An SFT may develop almost anywhere throughout the body, including the head and neck region, and is characterized by a broad spectrum of malignancy. Here we present a case involving a 57-year-old male with a dumbbell-shaped SFT in the cervical spine that mimicked schwannoma. Repeated fine-needle aspiration cytology failed to establish a definitive diagnosis. Given that the tumor size increased significantly over a 10-month period, open biopsy was then performed. Though the biopsy result was inconclusive, a nonepithelial tumor, including sclerosing epithelioid fibrosarcoma or ossifying fibromyxoid tumor, was suspected. The tumor was then completely removed together with adjacent parts of C2 and C3 vertebrae and left vertebral artery via combined anterior and posterior approaches. Histologically, the tumor consisted of round cells with prominent stromal hyalinization and was immunohistochemically positive for STAT6, CD34, and cytokeratin. Finally, Todai OncoPanel, a next-generation sequencing-based molecular profiling system using formalin-fixed paraffin-embedded samples, demonstrated fusion transcript in which NAB2 exon 6 was fused to STAT6 exon 16 supporting the diagnosis of SFT, while whole-exome sequencing analysis detected no somatic mutations which were known to be oncogenic. (C) 2019 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available